Intraneuronal amyloid β accumulation and oxidative damage to nucleic acids in Alzheimer disease

In an analysis of amyloid pathology in Alzheimer disease, we used an in situ approach to identify amyloid-β (Aβ) accumulation and oxidative damage to nucleic acids in postmortem brain tissue of the hippocampal formation from subjects with Alzheimer disease. When carboxyl-terminal-specific antibodies...

Full description

Saved in:
Bibliographic Details
Published inNeurobiology of disease Vol. 37; no. 3; pp. 731 - 737
Main Authors Nunomura, Akihiko, Tamaoki, Toshio, Tanaka, Koich, Motohashi, Nobutaka, Nakamura, Masao, Hayashi, Takaaki, Yamaguchi, Haruyasu, Shimohama, Shun, Lee, Hyoung-gon, Zhu, Xiongwei, Smith, Mark A., Perry, George
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.03.2010
Elsevier
Subjects
Online AccessGet full text
ISSN0969-9961
1095-953X
1095-953X
DOI10.1016/j.nbd.2009.12.012

Cover

Loading…
More Information
Summary:In an analysis of amyloid pathology in Alzheimer disease, we used an in situ approach to identify amyloid-β (Aβ) accumulation and oxidative damage to nucleic acids in postmortem brain tissue of the hippocampal formation from subjects with Alzheimer disease. When carboxyl-terminal-specific antibodies directed against Aβ40 and Aβ42 were used for immunocytochemical analyses, Aβ42 was especially apparent within the neuronal cytoplasm, at sites not detected by the antibody specific to Aβ-oligomer. In comparison to the Aβ42-positive neurons, neurons bearing oxidative damage to nucleic acids were more widely distributed in the hippocampus. Comparative density measurements of the immunoreactivity revealed that levels of intraneuronal Aβ42 were inversely correlated with levels of intraneuronal 8-hydroxyguanosine, an oxidized nucleoside ( r = − 0.61, p < 0.02). Together with recent evidence that the Aβ peptide can act as an antioxidant, these results suggest that intraneuronal accumulation of non-oligomeric Aβ may be a compensatory response in neurons to oxidative stress in Alzheimer disease.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0969-9961
1095-953X
1095-953X
DOI:10.1016/j.nbd.2009.12.012